Acutus Medical Stock

Acutus Medical FCF Yield

The Free Cash Flow Yield of Acutus Medical (AFIB) as of Aug 9, 2026 is -1.06 M %. In the previous year, Free Cash Flow Yield was -2.12 M % — a change of -49.84% (higher).

FCF Yield

-1.06 M %

YoY

-49.84%

Last updated:

Free Cash Flow Yield of Acutus Medical is 2026 -1.06 M % . Free Cash Flow Yield of Acutus Medical was 2025 -2.12 M % . It decreases by -49.84% higher compared to the previous year.
Access this data via the Eulerpool API

Acutus Medical Stock analysis

What does Acutus Medical do? The company Acutus Medical Inc was founded in 2011 and is headquartered in California, USA. The company aims to develop innovative technologies to improve the procedures in the diagnosis and treatment of heart disease. The company employs over 300 employees worldwide and has various locations in the USA and Europe. Acutus Medical Inc's business model is based on the development and marketing of products to improve the diagnosis and treatment options for heart disease. This includes both electrophysiological products for assessing heartbeats and treatment products for regulating heart rate. An important division of the company is electrophysiological diagnostics. Products are produced here that measure and record the electrical impulse of the heart. This is done, for example, through catheters that are inserted into the heart and use electromagnetic technologies to create an accurate mapping of the heart's electrical activity. This information can help doctors better understand the condition and function of the heart and make informed decisions regarding treatment. Another important area of Acutus Medical Inc is the therapy of heart disease. The company offers innovative treatment products that help regulate heart rhythm and treat cardiac arrhythmias. Particularly noteworthy here is the product "AcQMap," which enables the use of electromagnetic technologies for mapping the heart and identifying heart rhythm disorders. This allows doctors to develop more targeted treatment strategies and improve treatment accuracy. Another important division of Acutus Medical Inc is the research and development of new technologies to improve the diagnosis and therapy of heart disease. The company works closely with doctors and research institutes to drive product and procedure innovation. Overall, Acutus Medical Inc is an innovative company specializing in the development of technologies to improve the diagnosis and treatment of heart disease. The company operates internationally and offers a wide range of innovative products for electrophysiological diagnostics and therapy of heart disease. Through close collaboration with doctors and research institutes, Acutus Medical succeeds in improving existing procedures and developing new approaches for the treatment of heart disease. Acutus Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Acutus Medical stock

Free Cash Flow Yield of Acutus Medical is -1.06 M % in 2026.

Free Cash Flow Yield of Acutus Medical changed from -2.12 M % to -1.06 M %, representing a -49.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Acutus Medical since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Acutus Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Acutus Medical

All Key Metrics — Acutus Medical